Keywords: roche, trimeris, initiate, ph, iii, t-20, trials

Roche and Trimeris initiate Ph III T-20 trials

Article | 05 October 2000

Print This

Roche and Trimeris have initiated a Phase III trials program forT-20, the first in the new class of fusion inhibitors ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in